Cephalexin Dosing in Severe Renal Impairment (eGFR 8)
For a patient with eGFR 8 mL/min/1.73 m², cephalexin should be dosed at 250 mg every 12-24 hours, with treatment duration of 7-10 days depending on the infection type and clinical response.
Dose Adjustment Rationale
The FDA label does not provide specific renal dosing adjustments 1, but pharmacokinetic studies demonstrate critical alterations in cephalexin elimination with severe renal impairment:
- Normal half-life: ~1 hour 2, 3
- Anephric patients (CrCl 0): Half-life extends to 8.5-15.4 hours 2, 4
- Your patient (eGFR 8): Half-life approximately 7-8 hours
With a creatinine clearance near zero, the elimination rate constant drops dramatically (Ke = 0.0766 in anephric patients versus normal Ke = 0.73) 2. This means the drug accumulates significantly without dose reduction.
Specific Dosing Recommendations
Loading dose: 250-500 mg initially (based on infection severity)
Maintenance dosing:
- Mild-moderate infections: 250 mg every 12-24 hours
- Severe infections: 500 mg every 24 hours (maximum)
The pharmacokinetic correlation established shows: Ke = 0.0766 + 0.0060 × CrCl 2. With your patient's eGFR of 8, this yields a dramatically reduced elimination rate requiring substantial dose reduction from the standard 500 mg every 6 hours 1.
Duration of Therapy
Treatment duration depends on infection type:
- Skin and soft tissue infections: 7 days minimum 5
- Streptococcal infections: 10 days mandatory 1
- Uncomplicated cystitis: 7-14 days 1
The guideline emphasizes that β-hemolytic streptococcal infections require at least 10 days of therapy regardless of renal function 1.
Critical Monitoring Points
Watch for drug accumulation: Even with dose reduction, serum concentrations remain elevated for 24+ hours in severe renal impairment 6. Peak levels occur within 1 hour but can be delayed up to 6-12 hours in some anephric patients due to altered absorption 6.
Hemodialysis consideration: If your patient is on dialysis, cephalexin is partially removed (58% reduction over 6 hours) 6, 3, but antimicrobial activity persists 8+ hours post-dialysis. Supplemental dosing of 250 mg after dialysis may be needed.
Common Pitfalls to Avoid
- Do not use standard dosing: The typical 500 mg every 6 hours will cause severe accumulation and potential toxicity
- Do not assume linear dose reduction: The relationship between renal function and dosing is exponential, not linear
- Do not forget the loading dose: Initial therapeutic levels still require adequate loading, then reduced maintenance
- Avoid doses >4g daily: The FDA label explicitly states parenteral cephalosporins should be considered if >4g daily is needed 1, which is impossible to achieve safely at eGFR 8
Alternative Considerations
If higher doses are clinically required for severe infections, parenteral cephalosporins with appropriate renal dosing should be used instead 1. Cephalexin's prolonged half-life at this level of renal function makes aggressive oral dosing impractical and potentially dangerous.
The research demonstrates that patients with creatinine clearance <30 mL/min require proportional dose reduction 7, and your patient at eGFR 8 falls well below this threshold, necessitating the conservative approach outlined above.